Letter: Prostaglandin E1 therapy with alprostadil and risk reduction of early hepatic cellular carcinoma after liver transplantation - Authors' reply

A. Kornberg

doi:10.1111/apt.13468

Letter: Prostaglandin E1 therapy with alprostadil and risk reduction of early hepatic cellular carcinoma after liver transplantation - Authors' reply

Department of Surgery

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	173-174
Number of pages	2
Journal	Alimentary Pharmacology and Therapeutics
Volume	43
Issue number	1
DOIs	https://doi.org/10.1111/apt.13468
State	Published - 1 Jan 2016

Access to Document

10.1111/apt.13468

Cite this

@article{114bc9e85a1c4cef924e588e57ca1712,

title = "Letter: Prostaglandin E1 therapy with alprostadil and risk reduction of early hepatic cellular carcinoma after liver transplantation - Authors' reply",

author = "A. Kornberg",

year = "2016",

month = jan,

day = "1",

doi = "10.1111/apt.13468",

language = "English",

volume = "43",

pages = "173--174",

journal = "Alimentary Pharmacology and Therapeutics",

issn = "0269-2813",

publisher = "John Wiley and Sons Inc.",

number = "1",

}

TY - JOUR

T1 - Letter

T2 - Prostaglandin E1 therapy with alprostadil and risk reduction of early hepatic cellular carcinoma after liver transplantation - Authors' reply

AU - Kornberg, A.

PY - 2016/1/1

Y1 - 2016/1/1

UR - http://www.scopus.com/inward/record.url?scp=84949870623&partnerID=8YFLogxK

U2 - 10.1111/apt.13468

DO - 10.1111/apt.13468

M3 - Letter

C2 - 26638938

AN - SCOPUS:84949870623

SN - 0269-2813

VL - 43

SP - 173

EP - 174

JO - Alimentary Pharmacology and Therapeutics

JF - Alimentary Pharmacology and Therapeutics

IS - 1

ER -

Letter: Prostaglandin E1 therapy with alprostadil and risk reduction of early hepatic cellular carcinoma after liver transplantation - Authors' reply

Access to Document

Other files and links

Cite this